REFERENCES
- Marcus AJ: Platelet function. N Engl J Med 280:1213, 1969
- Ginsburg AD, Aster RH: Platelet function? Its clinical significance. DM, Sept 1970
- Packham MA, Mustard JF: Platelet reactions. Semin Hematol 8:30, 1971
- Weiss HJ: The pharmacology of platelet inhibition. In Spaet TH (Editor): Progress in Hemostasis and Thrombosis. New York, Grune & Stratton, Inc, 1972, p 199
- Hohnsen H: The platelet: Its membrane, physiology and biochemistry. Clinics Haematol 1:235, 1972
- Walsh PN: The role of platelets in the contact phase of blood coagulation. Br J Haematol 22:237, 1972
- Gimbrone MA Jr, Aster RH, Cotran RS, et al: Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature 221:33, 1969
- Clawson CC, White JG: Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol 65:381, 1971
- Nachman RL, Weksler B, Ferris B: Increased vascular permeability produced bv human platelet granule cationic extract. J Clin Invest 49:274, 1970
- Weksler BB, Coupal CE: Platelet-dependent generation of chemotactic activity in serum. J Exp Med 137:1419, 1973
- Weiss HJ: Bleeding disorders due to abnormal platelet function. Med Clin North Am 57:517, 1973
- tenCate JW: Platelet function tests. Clinics Haematol 1:283, 1972
- Cowan DH, Haut MJ: Platelet function in acute leukemia. J Lab Clin Med 79:893, 1972
- Mills DC: Drugs that affect platelet behavior. Clinics Haematol 1:295, 1972
- Kaneshiro MM, Mielke CH Jr, Kasper CK, et al: Bleeding time after aspirin in disorders of intrinsic clotting. N Engl J Med 281:1039, 1969
- Harker LA, Slichter SJ: Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med 283:1302, 1970
- Salzman EW, Harris WH, DeSanctis RW: Reduction in venous thromboembolism by agents affecting platelet function. N Engl J Med 284:1287, 1971
- Sullivan JM, Harken DE, Gorlin R: Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med 284:1391, 1971
- Aster RH: Thrombocytopenia due to enhanced platelet destruction. In Williams WJ, Buetler E, Erslev AJ, et al (Editors): Hematology. New York, McGraw-Hill Book Company, 1972, p 1131
- Eisner EV, Shahidi NT: Immune thrombocytopenia due to a drug metabolite. N Engl J Med 287:376, 1972
- Karpatkin S, Strick N, Karpatkin MB, et al: Cumulative experience in the detection of anti-platelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med 52:776, 1972
- Clancy R: Cellular immunity to autologous platelets and serum-blocking factors in idiopathic thrombocytopenic purpura. Lancet 1:6, 1972
- Amir J, Krauss S: Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs. Blood 42:27, 1973
- Cash JD: Platelet transfusion therapy. Clinics Haematol 1:395, 1972
- Yankee RA, Graff KS, Dowling R, et al: Selection of unrelated compatible platelet donors by lymphocyte HL-A matching. N Engl J Med 288:760, 1973